Transfection Reagents And Equipment Market To Reach $3.1 Billion By 2033

Transfection Reagents & Equipment Market Growth & Trends

The global transfection reagents and equipment market size is expected to reach USD 3.1 billion by 2033, registering a CAGR of 8.9% from 2026 to 2033, according to a new report by Grand View Research, Inc. The latest polymeric formulations-based compounds are gentle to cells as compared to cationic liposomes and these products render higher gene-delivery efficiency, further promoting the development of unique transfection products in the market.

Moreover, multi-component reagents such as X-tremeGENE provided by F. Hoffmann-La Roche AG, deliver high efficiency and minimal cytotoxicity than traditional ones comprising only one-component formulations. Thus, companies are keen on offering cutting-edge transfection solutions, in turn, offering significant momentum to market growth.

The gene expression studies segment dominated the market and account for the largest revenue share in 2019. This is attributed to the rising focus on the translation of genomic information in clinics. In addition, an increasing number of research projects related to the identification of chromosomal anomalies is anticipated to propel segment growth.

 Request a free sample copy or view report summary: Transfection Reagents & Equipment Market Report

Transfection Reagents & Equipment Market Report Highlights

• The reagent segment dominated the transfection reagents and equipment market and accounted for the largest revenue share of 53.1% in 2025. This dominance can be attributed to the large number of product launches by key players aimed at expanding their transfection reagent portfolios.

• The electroporation segment dominated the market, accounting for 22.2% of revenue in 2025. Wide portfolios of electroporation solutions offered by established and emerging players are boosting segment growth.

• The gene expression studies segment dominated the market, accounting for 22.6% of revenue in 2025. This is owing to the expansion of the genomic data pool and the rising emphasis on translating genomic information into clinical workflows.

• The pharmaceutical and biotechnology companies segment accounted for a substantial share of the transfection reagents & equipment market, driven by the extensive use of transfection technologies across drug discovery, biologics development, cell and gene therapy programs, target validation, process development, and commercial research activities.

• North America dominated the transfection reagents and equipment market, accounting for a 38.2% revenue share in 2025, supported by its advanced biotechnology ecosystem, strong concentration of biopharmaceutical innovators, and extensive cell and gene therapy development activities.

Transfection Reagents & Equipment Market Segmentation

Grand View Research has segmented the global transfection reagents and equipment market based on product, application, method, end use, and region:

Transfection Reagents & Equipment Product Scope Outlook (Revenue, USD Billion, 2021 - 2033)

• Reagents

• Equipment

Transfection Reagents & Equipment Method Scope Outlook (Revenue, USD Billion, 2021 - 2033)

• Electroporation

• Liposomes

• Particle Bombardment

• Microinjection

• Adenoviral Vectors

• Calcium Phosphate

• DEAE-dextran

• Magnetic Beads

• Activated Dendrimers

• Laserfection

Transfection Reagents & Equipment Application Outlook (Revenue, USD Billion, 2021 - 2033)

• Gene Expression Studies

• Protein Production

• Transgenic Models

• Therapeutic Delivery

• Cancer Research

• Biomedical Research

Transfection Reagents & Equipment End Use Outlook (Revenue, USD Billion, 2021 - 2033)

• Academic And Research Institutes

• Pharmaceutical And Biotechnology Companies

Transfection Reagents & Equipment Regional Scope Outlook (Revenue, USD Billion, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Transfection Reagents & Equipment Market

• Thermo Fisher Scientific, Inc.

• Promega Corporation

• Lonza

• QIAGEN

• F. Hoffmann-La Roche Ltd.

• Bio-Rad Laboratories Inc.

• Merck KGaA

• OriGene Technologies Inc.

• MaxCyte, Inc.

• POLYPLUS TRANSFECTION

• Horizon Discovery Ltd.

• PromoCell GmbH.